MedTrace Logo

The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites

NCT02755701 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2016-09-02

No results posted yet for this study

Summary

To compare the efficacy of branched-chain amino acid in serum albumin level in cirrhotic patients with ascites.

Conditions

  • Cirrhosis
  • Ascites

Interventions

DRUG

Branched-chain Amino Acid

BCAA (livact) will be administered 3 times a day during 24 weeks

DRUG

Placebo

Placebo will be administered in the same way

Sponsors & Collaborators

  • Severance Hospital

    collaborator OTHER

  • Kyunghee University

    collaborator OTHER

  • Wonju Severance Christian Hospital

    collaborator OTHER

  • Korea University Anam Hospital

    collaborator OTHER

  • Hanyang University

    collaborator OTHER

  • Stanford University

    collaborator OTHER

  • Soonchunhyang University Hospital

    lead OTHER

Principal Investigators

  • Sang Gyune Kim · Soon Chun Hyang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • United States
  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02755701 on ClinicalTrials.gov